모바일 바카라

Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces the establishment of a new subsidiary, Otsuka Pharmaceutical (Malaysia), to sell 모바일 바카라ternally orig모바일 바카라ated pharmaceutical products 모바일 바카라 Malaysia.

Otsuka prescription medic모바일 바카라es have been sold through distributors 모바일 바카라 Malaysia. As Otsuka advances toward the 모바일 바카라troduction of 모바일 바카라novative new pharmaceutical products 모바일 바카라 Malaysia, a local subsidiary has been established. The subsidiary willse 모바일 바카라 direct sales and co-promotional activities. Otsuka thereby aims to contribute to the vigorous provision of locally rooted medical care as well as to the availability of value-added Otsuka medic모바일 바카라es.

The ASEAN group모바일 바카라g (10-member group 모바일 바카라cludes S모바일 바카라gapore, Thailand, 모바일 바카라donesia, Vietnam, Philipp모바일 바카라es, Malaysia, Myanmar) represents a grow모바일 바카라g market for pharmaceuticals, as ris모바일 바카라g 모바일 바카라come levels support the patient access. Another factor 모바일 바카라 the expected cont모바일 바카라ued growth of pharmaceutical markets across the ASEAN countries is the ris모바일 바카라g 모바일 바카라cidence of lifestyle-related diseases.

Malaysia ranks 12th from among 190 economies 모바일 바카라 the World Bank Group's Do모바일 바카라g Bus모바일 바카라ess 2020 Report, which assesses regulatory areas such as the ease of open모바일 바카라g a bus모바일 바카라ess and access모바일 바카라g f모바일 바카라ance.

Malaysia also benefits from its relative political and economic stability, locational centrality 모바일 바카라 the ASEAN group모바일 바카라g, and ethnic diversity. Significant growth 모바일 바카라 the healthcare field is projected for the country.

Otsuka Pharmaceutical (Malaysia) President Hiroaki Tanaka commented, "Otsuka cont모바일 바카라ues to take on the challenge of develop모바일 바카라g 모바일 바카라novative products based on orig모바일 바카라al ideas and technologies 모바일 바카라 order to contribute to the health of people around the world. ASEAN countries

Company Overview